Lexapro (Major Depressive Disorder) Market Overview and Developments by 2023

Lexapro (Major Depressive Disorder) Market Size, Share, Trends, Company

Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,

Segmentation and Forecast To 2023

Summary

Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide.

The MDD market is a crowded and competitive market, with more than 30 marketed products

available for the treatment of patients with MDD. The depression market is about to enter a

dynamic phase with imminent patent expiries for top selling products, such as Eli Lilly's

Cymbalta, and Otsuka/BMS's Abilify, along with the recent launch of the multimodal

antidepressant, Lundbeck/Takeda's Brintellix, in January 2014, and the potential introduction of

seven promising late-stage pipeline products into the market during the forecast period, from

2013 to 2023.

Lexapro (escitalopram) is an SSRI that was developed by Lundbeck; it initially gained marketing

approval for MDD in 2002 in the US. Lexapro is the S-enantiomer of citalopram, an SSRI that

was also developed by Lundbeck, which first became available in 1989. Lexapro acts by binding

with high affinity to serotonin (5-HT), thereby inhibiting serotonin reuptake; this results in the

higher levels of serotonin that are believed to exert antidepressant effects.

For further information on this report, please visit http://www.radiantinsights.com/research/lexapro-major-depressive-disorder-forecast-andmarket-analysis-to-2023

Scope

- Overview of Major depressive disorder, including epidemiology, etiology, symptoms,

diagnosis, pathology and treatment guidelines as well as an overview on the competitive

landscape.

- Detailed information on Lexapro including product description, safety and efficacy profiles as

well as a SWOT analysis.

- Sales forecast for Lexapro for the top eight countries from 2013 to 2023.

- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan and

Australia.

Reasons to buy

- Understand...